Today: 9 June 2026
Browse Category

NASDAQ:IREN.O 29 December 2025 - 28 February 2026

IREN stock price slides 6% as bitcoin dips again — what traders watch next

IREN stock price slides 6% as bitcoin dips again — what traders watch next

IREN shares dropped 6.1% to $40.06 in Thursday afternoon trading, outpacing declines in other crypto miners as bitcoin fell 2.7% to $65,559. HC Wainwright cut IREN’s earnings forecasts but kept a “Buy” rating. Investors pulled back from risk assets ahead of Friday’s U.S. CPI report. Treasury yields slipped as traders adjusted Fed rate-cut bets.
12 February 2026
······
IREN stock climbs in premarket as Bernstein backs the AI-cloud miner with U.S. jobs data due

IREN stock climbs in premarket as Bernstein backs the AI-cloud miner with U.S. jobs data due

IREN shares rose 4.7% to $45.68 in premarket trading Friday, after closing at $43.63 Thursday. Bernstein maintained IREN as its “top AI pick” with a $75 target, while J.P. Morgan reaffirmed a sell rating. Traders are watching the U.S. jobs report at 8:30 a.m. ET and bitcoin’s price, which was up 0.5% at about $90,337. IREN’s outlook remains tied to a $9.7 billion Microsoft GPU cloud contract.
9 January 2026
·····
IREN stock jumps nearly 8% as AI data-center trade returns; earnings are the next test

IREN stock jumps nearly 8% as AI data-center trade returns; earnings are the next test

IREN shares jumped 7.7% to $46.99 in Thursday afternoon trading, tracking gains in data-center stocks after Applied Digital announced talks with a major cloud customer. IREN operates U.S. and Canadian data centers for bitcoin mining and AI compute, with about 1,896 Nvidia GPUs. Its $9.7 billion, five-year GPU cloud deal with Microsoft includes strict delivery terms. Next results are expected in February, with focus on GPU rollout and funding.
8 January 2026
····

Stock Market Today

  • Great Western Mining Issues TR-1 Major Shareholder Disclosure
    June 9, 2026, 10:36 AM EDT. Great Western Mining (GWMOF) announced a TR-1 notification of major holdings on June 9, 2026, via the Regulatory News Service (RNS) in Dublin. This disclosure highlights significant shareholdings in the company, providing investors with transparency on ownership stakes. The official document detailing the holdings is accessible via the London Stock Exchange website, ensuring market participants can review the full data. Such filings comply with regulatory requirements to keep the market informed of notable shareholder positions and maintain market integrity. The TR-1 form is a standard channel for reporting these substantial holdings in UK-listed companies.

Latest articles

Autozi Shares Jump 400%, Filing Flags Risks for AZI

Autozi Shares Jump 400%, Filing Flags Risks for AZI

9 June 2026
Autozi Internet Technology shares soared over 400% to $5.69 in early Nasdaq trading after a 10-for-1 share consolidation slashed its share count to about 4.49 million, but the surge contrasts with a 63.1% revenue drop, 82.5% plunge in gross profit, and widened net loss, with the company warning of “substantial doubt” about its ability to continue as a going concern.
Redwire Shares Slip After $500 Million Stock Offering Filed

Redwire Shares Slip After $500 Million Stock Offering Filed

9 June 2026
Redwire Corp shares plunged 6.5% to $17.37 after launching a $500 million at-the-market stock program, raising dilution risks for investors as the company seeks flexible funding despite recent record backlog and strong revenue growth; the drop contrasted with gains at other space stocks, highlighting investor concern over potential share issuance.
Nuvalent Trades Close to $124 After GSK’s $10.6 Billion Offer

Nuvalent Trades Close to $124 After GSK’s $10.6 Billion Offer

9 June 2026
Nuvalent shares soared 38.9% to $122.93, just below GSK’s $124-a-share cash offer after the $10.6 billion buyout was announced, as investors bet on the deal closing with Nuvalent’s two lead lung-cancer drugs already under FDA review and a 40% premium to the last closing price driving the morning’s merger-arb trade.
Regentis Biomaterials Stock: Tiny RGNT Is Back In Focus Before The Bell

Regentis Biomaterials Stock: Tiny RGNT Is Back In Focus Before The Bell

9 June 2026
Regentis Biomaterials shares dipped 2 cents to $1.28 premarket after the company announced European surgeon training for its GelrinC knee implant will begin in Q3, marking a key commercial step but leaving investors waiting for revenue proof as the stock trades far below its $8 IPO price.
Go toTop